The laborious process of naming a pharmaceutical takes months and sometimes years of brainstorming, trademark review, legal ...
Wanted: a cheap, multipotent treatment for viral infections. Must be able to handle new or unfamiliar strains, or (even ...
The US Food and Drug Administration (FDA) on Monday announced it will pilot a new program it hopes will spur the development of novel drug development tools (DDTs) that do not fit within the agency’s ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
The process of discovering new drugs and bringing them to market is notoriously slow and inefficient. Amazon Web Services is ...
Twelve months after releasing a roadmap to shift away from animal testing requirements, the FDA has declared mission ...
SAN DIEGO , CA, UNITED STATES, April 17, 2026 /EINPresswire.com/ -- In today’s life sciences landscape, the journey ...
SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to major medical advances -- but it ...
Hosted on MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based biotech start-up MindRank has progressed to Phase 3 clinical trials for its ...
It’s the latest example of a pharmaceutical giant trying to use AI to discover and manufacture new therapies faster. Pharmaceutical giant Roche said today it is launching a new large-scale “AI factory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results